Dr Joanne Hart

Lecturer MD Program, Sydney Medical School / Sydney Medical School's Education Office

Telephone +61 2 9036 3402

Map

Biographical details

Dr Hart is a pharmcologist with a research background in basic vascular physiology. Her research work includes vasoactive effects of gaseous mediators, including NO and H2S and novel drugs that have the potential to reduce diabetes-induced vascular oxidative stress. She has extensive University teaching experience, particularly in pharmacology, and is an experienced higher degree research project supervisor. She has recently joined the academic teaching team that supports the MD Research Projects.

Research interests

Role of gaseous mediators in vascular function

Oxidative stress in vascular disease

Diabetes-related vascular complications

Project-based learning and curriculum developments

Teaching and supervision

Dr Hart has extensive teaching experience in pharmacology, physiology, therapeutics and research methods. She is an experienced Honours and higher degree research supervisor and co-ordinator. Recently she has been involved with developments in project-based learning and assisted the Faculty of Science with introducing project-based units of study in their majors. She has experience in curriculum development and evaluation.

Current projects

Dr Hart is the Chief Investigator on:

Evaluating the effectiveness of project-based learning for development of the Graduate Qualities and enhancing the student ecxperience. Project # 2018/368

Associations

Australian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)

Biosciences Education Australia (BEAN)

Australian Conference on Science and Mathematics Education (ACSME)

Australian Collaborative Education Network (ACEN)

Selected grants

2018

  • STEM in the Workplace; Casson-Medhurst D, Hart J; DVC Education/Small Educational Innovation Grant.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Ng, H., Yildiz, G., Ku, J., Miller, A., Woodman, O., Hart, J. (2017). Chronic NaHS treatment decreases oxidative stress and improves endothelial function in diabetic mice. Diabetes and Vascular Disease Research, 14(3), 246-253. [More Information]
  • Caprnda, M., Qaradakhi, T., Hart, J., Kobyliak, N., Opatrilova, R., Kruzliak, P., Zulli, A. (2017). H2S causes contraction and relaxation of major arteries of the rabbit. Biomedicine and Pharmacotherapy, 89, 56-60. [More Information]
  • Jenkins, T., Nguyen, J., Hart, J. (2016). Decreased vascular H2S production is associated with vascular oxidative stress in rats fed a high-fat western diet. Naunyn-Schmiedeberg's Archives of Pharmacology, 389(7), 783-790. [More Information]
  • Al-Magableh, M., Kemp-Harper, B., Hart, J. (2015). Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice. Hypertension Research, 38(1), 13-20. [More Information]
  • Al-Magableh, M., Kemp-Harper, B., Ng, H., Miller, A., Hart, J. (2014). Hydrogen sulfide protects endothelial nitric oxide function under conditions of acute oxidative stress in vitro. Naunyn-Schmiedeberg's Archives of Pharmacology, 387(1), 67-74. [More Information]
  • Lloyd, H., Hinton, T., Bullock, S., Babey, A., Davis, E., Fernandes, L., Hart, J., Musgrave, I., Ziogas, J. (2013). An evaluation of pharmacology curricula in Australian science and health-related degree programs. BMC Medical Education, 13(1), 1-15. [More Information]
  • Ford, A., Al-Magableh, M., Gaspari, T., Hart, J. (2013). Chronic NaHS treatment is vasoprotective in high-fat-fed ApoE-/- mice. International Journal of Vascular Medicine, 2013, 1-8. [More Information]
  • Streeter, E., Badoer, E., Woodman, O., Hart, J. (2013). Effect of type 1 diabetes on the production and vasoactivity of hydrogen sulfide in rat middle cerebral arteries. Physiological Reports, 1(5), 1-10. [More Information]
  • Streeter, E., Ng, H., Hart, J. (2013). Hydrogen sulfide as a vasculoprotective factor. BioMed Central, 3(6). [More Information]
  • Streeter, E., Ng, H., Hart, J. (2013). Hydrogen sulfide as a vasculoprotective factor. BioMed Central, 3(9). [More Information]
  • Streeter, E., Hart, J., Badoer, E. (2012). An investigation of the mechanisms of hydrogen sulfide-induced vasorelaxation in rat middle cerebral arteries. Naunyn-Schmiedeberg's Archives of Pharmacology, 385(10), 991-1002. [More Information]
  • Leo, C., Joshi, A., Hart, J., Woodman, O. (2012). Endothelium-dependent nitroxyl-mediated relaxation is resistant to superoxide anion scavenging and preserved in diabetic rat aorta. Pharmacological Research, 66(5), 383-391. [More Information]
  • Leo, C., Hart, J., Woodman, O. (2011). 3',4'-dihydroxyflavonol reduces superoxide and improves nitric oxide function in diabetic rat mesenteric arteries. PloS One, 6(6), 1-11. [More Information]
  • Leo, C., Hart, J., Woodman, O. (2011). 3',4'-Dihydroxyflavonol restores endothelium-dependent relaxation in small mesenteric artery from rats with type 1 and type 2 diabetes. European Journal of Pharmacology, 659(2-3), 193-198. [More Information]
  • Streeter, E., Al-Magableh, M., Hart, J., Badoer, E. (2011). Hydrogen sulfide in the RVLM and PVN has no effect on cardiovascular regulation. Frontiers in Physiology, 2, 1-8. [More Information]
  • Leo, C., Hart, J., Woodman, O. (2011). Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes. British Journal of Pharmacology, 162(2), 365-377. [More Information]
  • Al-Magableh, M., Hart, J. (2011). Mechanism of vasorelaxation and role of endogenous hydrogen sulfide production in mouse aorta. Naunyn-Schmiedeberg's Archives of Pharmacology, 383(4), 403-413. [More Information]
  • Hart, J. (2011). Role of sulfur-containing gaseous substances in the cardiovascular system. Frontiers in Bioscience, 3E(2), 736-749.

2017

  • Ng, H., Yildiz, G., Ku, J., Miller, A., Woodman, O., Hart, J. (2017). Chronic NaHS treatment decreases oxidative stress and improves endothelial function in diabetic mice. Diabetes and Vascular Disease Research, 14(3), 246-253. [More Information]
  • Caprnda, M., Qaradakhi, T., Hart, J., Kobyliak, N., Opatrilova, R., Kruzliak, P., Zulli, A. (2017). H2S causes contraction and relaxation of major arteries of the rabbit. Biomedicine and Pharmacotherapy, 89, 56-60. [More Information]

2016

  • Jenkins, T., Nguyen, J., Hart, J. (2016). Decreased vascular H2S production is associated with vascular oxidative stress in rats fed a high-fat western diet. Naunyn-Schmiedeberg's Archives of Pharmacology, 389(7), 783-790. [More Information]

2015

  • Al-Magableh, M., Kemp-Harper, B., Hart, J. (2015). Hydrogen sulfide treatment reduces blood pressure and oxidative stress in angiotensin II-induced hypertensive mice. Hypertension Research, 38(1), 13-20. [More Information]

2014

  • Al-Magableh, M., Kemp-Harper, B., Ng, H., Miller, A., Hart, J. (2014). Hydrogen sulfide protects endothelial nitric oxide function under conditions of acute oxidative stress in vitro. Naunyn-Schmiedeberg's Archives of Pharmacology, 387(1), 67-74. [More Information]

2013

  • Lloyd, H., Hinton, T., Bullock, S., Babey, A., Davis, E., Fernandes, L., Hart, J., Musgrave, I., Ziogas, J. (2013). An evaluation of pharmacology curricula in Australian science and health-related degree programs. BMC Medical Education, 13(1), 1-15. [More Information]
  • Ford, A., Al-Magableh, M., Gaspari, T., Hart, J. (2013). Chronic NaHS treatment is vasoprotective in high-fat-fed ApoE-/- mice. International Journal of Vascular Medicine, 2013, 1-8. [More Information]
  • Streeter, E., Badoer, E., Woodman, O., Hart, J. (2013). Effect of type 1 diabetes on the production and vasoactivity of hydrogen sulfide in rat middle cerebral arteries. Physiological Reports, 1(5), 1-10. [More Information]
  • Streeter, E., Ng, H., Hart, J. (2013). Hydrogen sulfide as a vasculoprotective factor. BioMed Central, 3(6). [More Information]
  • Streeter, E., Ng, H., Hart, J. (2013). Hydrogen sulfide as a vasculoprotective factor. BioMed Central, 3(9). [More Information]

2012

  • Streeter, E., Hart, J., Badoer, E. (2012). An investigation of the mechanisms of hydrogen sulfide-induced vasorelaxation in rat middle cerebral arteries. Naunyn-Schmiedeberg's Archives of Pharmacology, 385(10), 991-1002. [More Information]
  • Leo, C., Joshi, A., Hart, J., Woodman, O. (2012). Endothelium-dependent nitroxyl-mediated relaxation is resistant to superoxide anion scavenging and preserved in diabetic rat aorta. Pharmacological Research, 66(5), 383-391. [More Information]

2011

  • Leo, C., Hart, J., Woodman, O. (2011). 3',4'-dihydroxyflavonol reduces superoxide and improves nitric oxide function in diabetic rat mesenteric arteries. PloS One, 6(6), 1-11. [More Information]
  • Leo, C., Hart, J., Woodman, O. (2011). 3',4'-Dihydroxyflavonol restores endothelium-dependent relaxation in small mesenteric artery from rats with type 1 and type 2 diabetes. European Journal of Pharmacology, 659(2-3), 193-198. [More Information]
  • Streeter, E., Al-Magableh, M., Hart, J., Badoer, E. (2011). Hydrogen sulfide in the RVLM and PVN has no effect on cardiovascular regulation. Frontiers in Physiology, 2, 1-8. [More Information]
  • Leo, C., Hart, J., Woodman, O. (2011). Impairment of both nitric oxide-mediated and EDHF-type relaxation in small mesenteric arteries from rats with streptozotocin-induced diabetes. British Journal of Pharmacology, 162(2), 365-377. [More Information]
  • Al-Magableh, M., Hart, J. (2011). Mechanism of vasorelaxation and role of endogenous hydrogen sulfide production in mouse aorta. Naunyn-Schmiedeberg's Archives of Pharmacology, 383(4), 403-413. [More Information]
  • Hart, J. (2011). Role of sulfur-containing gaseous substances in the cardiovascular system. Frontiers in Bioscience, 3E(2), 736-749.

To update your profile click here. For support on your academic profile contact .